nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CYP2D6—Lomustine—brain cancer	0.224	0.303	CbGbCtD
Darifenacin—CYP2D6—Hydroxyurea—brain cancer	0.17	0.23	CbGbCtD
Darifenacin—CYP3A4—Temozolomide—brain cancer	0.168	0.227	CbGbCtD
Darifenacin—CYP3A4—Lomustine—brain cancer	0.143	0.193	CbGbCtD
Darifenacin—CYP3A4—Etoposide—brain cancer	0.0345	0.0466	CbGbCtD
Darifenacin—Visual disturbance—Lomustine—brain cancer	0.00514	0.0201	CcSEcCtD
Darifenacin—Stomatitis—Lomustine—brain cancer	0.00366	0.0143	CcSEcCtD
Darifenacin—Visual impairment—Lomustine—brain cancer	0.00325	0.0127	CcSEcCtD
Darifenacin—Accidental injury—Carmustine—brain cancer	0.00302	0.0118	CcSEcCtD
Darifenacin—Thinking abnormal—Carmustine—brain cancer	0.00291	0.0114	CcSEcCtD
Darifenacin—Infection—Carboplatin—brain cancer	0.00272	0.0106	CcSEcCtD
Darifenacin—Vaginal inflammation—Temozolomide—brain cancer	0.00258	0.0101	CcSEcCtD
Darifenacin—Vaginal infection—Temozolomide—brain cancer	0.00243	0.00949	CcSEcCtD
Darifenacin—Dry eye—Temozolomide—brain cancer	0.00238	0.00929	CcSEcCtD
Darifenacin—Infection—Lomustine—brain cancer	0.00238	0.00928	CcSEcCtD
Darifenacin—Pain—Carboplatin—brain cancer	0.00234	0.00913	CcSEcCtD
Darifenacin—Abnormal vision—Carmustine—brain cancer	0.00233	0.00907	CcSEcCtD
Darifenacin—Stomatitis—Procarbazine—brain cancer	0.00233	0.00907	CcSEcCtD
Darifenacin—Mental disability—Carmustine—brain cancer	0.00232	0.00903	CcSEcCtD
Darifenacin—Face oedema—Hydroxyurea—brain cancer	0.00231	0.00902	CcSEcCtD
Darifenacin—Sweating—Procarbazine—brain cancer	0.00229	0.00892	CcSEcCtD
Darifenacin—Abnormal vision—Temozolomide—brain cancer	0.00225	0.00877	CcSEcCtD
Darifenacin—Mental disability—Temozolomide—brain cancer	0.00224	0.00873	CcSEcCtD
Darifenacin—Breast disorder—Hydroxyurea—brain cancer	0.00216	0.00844	CcSEcCtD
Darifenacin—Hallucination—Procarbazine—brain cancer	0.00213	0.00831	CcSEcCtD
Darifenacin—Injury—Carmustine—brain cancer	0.00211	0.00822	CcSEcCtD
Darifenacin—Weight increased—Hydroxyurea—brain cancer	0.00188	0.00735	CcSEcCtD
Darifenacin—Face oedema—Carmustine—brain cancer	0.00187	0.00729	CcSEcCtD
Darifenacin—Mouth ulceration—Etoposide—brain cancer	0.00187	0.00727	CcSEcCtD
Darifenacin—Infestation NOS—Hydroxyurea—brain cancer	0.00185	0.0072	CcSEcCtD
Darifenacin—Infestation—Hydroxyurea—brain cancer	0.00185	0.0072	CcSEcCtD
Darifenacin—Face oedema—Temozolomide—brain cancer	0.00181	0.00705	CcSEcCtD
Darifenacin—Stomatitis—Hydroxyurea—brain cancer	0.0018	0.00702	CcSEcCtD
Darifenacin—Dry skin—Temozolomide—brain cancer	0.00172	0.00669	CcSEcCtD
Darifenacin—Breast disorder—Temozolomide—brain cancer	0.00169	0.0066	CcSEcCtD
Darifenacin—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.00169	0.00657	CcSEcCtD
Darifenacin—Syncope—Procarbazine—brain cancer	0.00167	0.00652	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00165	0.00644	CcSEcCtD
Darifenacin—Hallucination—Hydroxyurea—brain cancer	0.00165	0.00643	CcSEcCtD
Darifenacin—Loss of consciousness—Procarbazine—brain cancer	0.00164	0.00639	CcSEcCtD
Darifenacin—Cough—Procarbazine—brain cancer	0.00163	0.00634	CcSEcCtD
Darifenacin—Hypertension—Procarbazine—brain cancer	0.00161	0.00628	CcSEcCtD
Darifenacin—Arthralgia—Procarbazine—brain cancer	0.00159	0.00619	CcSEcCtD
Darifenacin—Bronchitis—Temozolomide—brain cancer	0.00156	0.00607	CcSEcCtD
Darifenacin—Dry mouth—Procarbazine—brain cancer	0.00155	0.00605	CcSEcCtD
Darifenacin—Confusional state—Procarbazine—brain cancer	0.00153	0.00598	CcSEcCtD
Darifenacin—Vomiting—Lomustine—brain cancer	0.00152	0.00594	CcSEcCtD
Darifenacin—Oedema—Procarbazine—brain cancer	0.00152	0.00593	CcSEcCtD
Darifenacin—Infection—Procarbazine—brain cancer	0.00151	0.00589	CcSEcCtD
Darifenacin—Angiopathy—Hydroxyurea—brain cancer	0.0015	0.00586	CcSEcCtD
Darifenacin—Shock—Procarbazine—brain cancer	0.0015	0.00584	CcSEcCtD
Darifenacin—Erectile dysfunction—Temozolomide—brain cancer	0.00149	0.00581	CcSEcCtD
Darifenacin—Tachycardia—Procarbazine—brain cancer	0.00148	0.00579	CcSEcCtD
Darifenacin—Weight increased—Temozolomide—brain cancer	0.00147	0.00574	CcSEcCtD
Darifenacin—Hyperhidrosis—Procarbazine—brain cancer	0.00147	0.00574	CcSEcCtD
Darifenacin—Stomatitis—Carmustine—brain cancer	0.00145	0.00567	CcSEcCtD
Darifenacin—Urinary tract infection—Carmustine—brain cancer	0.00145	0.00566	CcSEcCtD
Darifenacin—Infestation NOS—Temozolomide—brain cancer	0.00144	0.00562	CcSEcCtD
Darifenacin—Infestation—Temozolomide—brain cancer	0.00144	0.00562	CcSEcCtD
Darifenacin—Nausea—Lomustine—brain cancer	0.00142	0.00555	CcSEcCtD
Darifenacin—Stomatitis—Temozolomide—brain cancer	0.00141	0.00548	CcSEcCtD
Darifenacin—Urinary tract infection—Temozolomide—brain cancer	0.0014	0.00547	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00139	0.00541	CcSEcCtD
Darifenacin—Insomnia—Procarbazine—brain cancer	0.00138	0.00537	CcSEcCtD
Darifenacin—Sinusitis—Temozolomide—brain cancer	0.00135	0.00528	CcSEcCtD
Darifenacin—Somnolence—Procarbazine—brain cancer	0.00135	0.00527	CcSEcCtD
Darifenacin—Hallucination—Carmustine—brain cancer	0.00133	0.0052	CcSEcCtD
Darifenacin—Alanine aminotransferase increased—Etoposide—brain cancer	0.00132	0.00515	CcSEcCtD
Darifenacin—Oedema peripheral—Carmustine—brain cancer	0.00132	0.00515	CcSEcCtD
Darifenacin—Pain—Procarbazine—brain cancer	0.0013	0.00507	CcSEcCtD
Darifenacin—Constipation—Procarbazine—brain cancer	0.0013	0.00507	CcSEcCtD
Darifenacin—Visual impairment—Carmustine—brain cancer	0.00129	0.00504	CcSEcCtD
Darifenacin—Hallucination—Temozolomide—brain cancer	0.00129	0.00502	CcSEcCtD
Darifenacin—Pharyngitis—Temozolomide—brain cancer	0.00128	0.00501	CcSEcCtD
Darifenacin—Urinary tract disorder—Temozolomide—brain cancer	0.00128	0.00499	CcSEcCtD
Darifenacin—Oedema peripheral—Temozolomide—brain cancer	0.00128	0.00497	CcSEcCtD
Darifenacin—Urethral disorder—Temozolomide—brain cancer	0.00127	0.00495	CcSEcCtD
Darifenacin—Feeling abnormal—Procarbazine—brain cancer	0.00125	0.00489	CcSEcCtD
Darifenacin—Eye disorder—Carmustine—brain cancer	0.00125	0.00488	CcSEcCtD
Darifenacin—Visual impairment—Temozolomide—brain cancer	0.00125	0.00487	CcSEcCtD
Darifenacin—Gastrointestinal pain—Procarbazine—brain cancer	0.00124	0.00485	CcSEcCtD
Darifenacin—Erythema multiforme—Temozolomide—brain cancer	0.00122	0.00477	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00122	0.00476	CcSEcCtD
Darifenacin—Eye disorder—Temozolomide—brain cancer	0.00121	0.00472	CcSEcCtD
Darifenacin—Abdominal pain—Procarbazine—brain cancer	0.0012	0.00469	CcSEcCtD
Darifenacin—Oedema—Hydroxyurea—brain cancer	0.00118	0.00459	CcSEcCtD
Darifenacin—Angiopathy—Temozolomide—brain cancer	0.00117	0.00458	CcSEcCtD
Darifenacin—Mental disorder—Carmustine—brain cancer	0.00117	0.00458	CcSEcCtD
Darifenacin—Infection—Hydroxyurea—brain cancer	0.00117	0.00456	CcSEcCtD
Darifenacin—Mediastinal disorder—Temozolomide—brain cancer	0.00117	0.00455	CcSEcCtD
Darifenacin—Nervous system disorder—Hydroxyurea—brain cancer	0.00115	0.0045	CcSEcCtD
Darifenacin—Infestation NOS—Etoposide—brain cancer	0.00115	0.0045	CcSEcCtD
Darifenacin—Infestation—Etoposide—brain cancer	0.00115	0.0045	CcSEcCtD
Darifenacin—Skin disorder—Hydroxyurea—brain cancer	0.00114	0.00446	CcSEcCtD
Darifenacin—Mental disorder—Temozolomide—brain cancer	0.00113	0.00442	CcSEcCtD
Darifenacin—Back pain—Carmustine—brain cancer	0.00113	0.0044	CcSEcCtD
Darifenacin—Stomatitis—Etoposide—brain cancer	0.00112	0.00439	CcSEcCtD
Darifenacin—Hypersensitivity—Procarbazine—brain cancer	0.00112	0.00437	CcSEcCtD
Darifenacin—Dysgeusia—Temozolomide—brain cancer	0.0011	0.0043	CcSEcCtD
Darifenacin—Vision blurred—Carmustine—brain cancer	0.0011	0.00429	CcSEcCtD
Darifenacin—Asthenia—Procarbazine—brain cancer	0.00109	0.00426	CcSEcCtD
Darifenacin—Back pain—Temozolomide—brain cancer	0.00109	0.00425	CcSEcCtD
Darifenacin—Pruritus—Procarbazine—brain cancer	0.00108	0.0042	CcSEcCtD
Darifenacin—Vision blurred—Temozolomide—brain cancer	0.00106	0.00414	CcSEcCtD
Darifenacin—Dyspnoea—Hydroxyurea—brain cancer	0.00105	0.00409	CcSEcCtD
Darifenacin—Somnolence—Hydroxyurea—brain cancer	0.00105	0.00408	CcSEcCtD
Darifenacin—Diarrhoea—Procarbazine—brain cancer	0.00104	0.00406	CcSEcCtD
Darifenacin—Dyspepsia—Hydroxyurea—brain cancer	0.00104	0.00404	CcSEcCtD
Darifenacin—Angioedema—Temozolomide—brain cancer	0.00103	0.00402	CcSEcCtD
Darifenacin—Urinary tract disorder—Etoposide—brain cancer	0.00102	0.00399	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00102	0.00396	CcSEcCtD
Darifenacin—Urethral disorder—Etoposide—brain cancer	0.00102	0.00396	CcSEcCtD
Darifenacin—Hypertension—Carmustine—brain cancer	0.00101	0.00393	CcSEcCtD
Darifenacin—Pain—Hydroxyurea—brain cancer	0.00101	0.00393	CcSEcCtD
Darifenacin—Constipation—Hydroxyurea—brain cancer	0.00101	0.00393	CcSEcCtD
Darifenacin—Dizziness—Procarbazine—brain cancer	0.00101	0.00392	CcSEcCtD
Darifenacin—Palpitations—Temozolomide—brain cancer	0.000996	0.00388	CcSEcCtD
Darifenacin—Cough—Temozolomide—brain cancer	0.000983	0.00384	CcSEcCtD
Darifenacin—Erythema multiforme—Etoposide—brain cancer	0.00098	0.00382	CcSEcCtD
Darifenacin—Hypertension—Temozolomide—brain cancer	0.000973	0.00379	CcSEcCtD
Darifenacin—Feeling abnormal—Hydroxyurea—brain cancer	0.00097	0.00378	CcSEcCtD
Darifenacin—Eye disorder—Etoposide—brain cancer	0.000968	0.00378	CcSEcCtD
Darifenacin—Vomiting—Procarbazine—brain cancer	0.000967	0.00377	CcSEcCtD
Darifenacin—Confusional state—Carmustine—brain cancer	0.00096	0.00374	CcSEcCtD
Darifenacin—Arthralgia—Temozolomide—brain cancer	0.00096	0.00374	CcSEcCtD
Darifenacin—Rash—Procarbazine—brain cancer	0.000959	0.00374	CcSEcCtD
Darifenacin—Dermatitis—Procarbazine—brain cancer	0.000958	0.00374	CcSEcCtD
Darifenacin—Headache—Procarbazine—brain cancer	0.000953	0.00372	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000953	0.00372	CcSEcCtD
Darifenacin—Oedema—Carmustine—brain cancer	0.000952	0.00371	CcSEcCtD
Darifenacin—Infection—Carmustine—brain cancer	0.000946	0.00369	CcSEcCtD
Darifenacin—Angiopathy—Etoposide—brain cancer	0.00094	0.00367	CcSEcCtD
Darifenacin—Dry mouth—Temozolomide—brain cancer	0.000938	0.00366	CcSEcCtD
Darifenacin—Mediastinal disorder—Etoposide—brain cancer	0.000934	0.00364	CcSEcCtD
Darifenacin—Tachycardia—Carmustine—brain cancer	0.000929	0.00362	CcSEcCtD
Darifenacin—Confusional state—Temozolomide—brain cancer	0.000927	0.00362	CcSEcCtD
Darifenacin—Anaphylactic shock—Temozolomide—brain cancer	0.00092	0.00359	CcSEcCtD
Darifenacin—Oedema—Temozolomide—brain cancer	0.00092	0.00359	CcSEcCtD
Darifenacin—Infection—Temozolomide—brain cancer	0.000914	0.00356	CcSEcCtD
Darifenacin—Clotrimazole—CYP2C9—brain cancer	0.00091	0.63	CrCbGaD
Darifenacin—Nausea—Procarbazine—brain cancer	0.000904	0.00352	CcSEcCtD
Darifenacin—Nervous system disorder—Temozolomide—brain cancer	0.000902	0.00352	CcSEcCtD
Darifenacin—Skin disorder—Temozolomide—brain cancer	0.000893	0.00348	CcSEcCtD
Darifenacin—Hyperhidrosis—Temozolomide—brain cancer	0.000889	0.00347	CcSEcCtD
Darifenacin—Dysgeusia—Etoposide—brain cancer	0.000883	0.00344	CcSEcCtD
Darifenacin—Back pain—Etoposide—brain cancer	0.000872	0.0034	CcSEcCtD
Darifenacin—Hypersensitivity—Hydroxyurea—brain cancer	0.000867	0.00338	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Carmustine—brain cancer	0.000867	0.00338	CcSEcCtD
Darifenacin—Insomnia—Carmustine—brain cancer	0.000861	0.00336	CcSEcCtD
Darifenacin—Dyspnoea—Carmustine—brain cancer	0.000849	0.00331	CcSEcCtD
Darifenacin—Somnolence—Carmustine—brain cancer	0.000846	0.0033	CcSEcCtD
Darifenacin—Asthenia—Hydroxyurea—brain cancer	0.000845	0.00329	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000838	0.00327	CcSEcCtD
Darifenacin—Insomnia—Temozolomide—brain cancer	0.000832	0.00324	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Carmustine—brain cancer	0.000822	0.0032	CcSEcCtD
Darifenacin—Dyspnoea—Temozolomide—brain cancer	0.00082	0.0032	CcSEcCtD
Darifenacin—Somnolence—Temozolomide—brain cancer	0.000818	0.00319	CcSEcCtD
Darifenacin—Pain—Carmustine—brain cancer	0.000814	0.00317	CcSEcCtD
Darifenacin—Constipation—Carmustine—brain cancer	0.000814	0.00317	CcSEcCtD
Darifenacin—Dyspepsia—Temozolomide—brain cancer	0.00081	0.00316	CcSEcCtD
Darifenacin—Diarrhoea—Hydroxyurea—brain cancer	0.000806	0.00314	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Temozolomide—brain cancer	0.000794	0.0031	CcSEcCtD
Darifenacin—Loss of consciousness—Etoposide—brain cancer	0.000793	0.00309	CcSEcCtD
Darifenacin—Cough—Etoposide—brain cancer	0.000787	0.00307	CcSEcCtD
Darifenacin—Pain—Temozolomide—brain cancer	0.000787	0.00307	CcSEcCtD
Darifenacin—Constipation—Temozolomide—brain cancer	0.000787	0.00307	CcSEcCtD
Darifenacin—Feeling abnormal—Carmustine—brain cancer	0.000784	0.00306	CcSEcCtD
Darifenacin—Hypertension—Etoposide—brain cancer	0.000779	0.00304	CcSEcCtD
Darifenacin—Dizziness—Hydroxyurea—brain cancer	0.000779	0.00304	CcSEcCtD
Darifenacin—Gastrointestinal pain—Carmustine—brain cancer	0.000778	0.00304	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000763	0.00297	CcSEcCtD
Darifenacin—Feeling abnormal—Temozolomide—brain cancer	0.000758	0.00296	CcSEcCtD
Darifenacin—Abdominal pain—Carmustine—brain cancer	0.000752	0.00293	CcSEcCtD
Darifenacin—Gastrointestinal pain—Temozolomide—brain cancer	0.000752	0.00293	CcSEcCtD
Darifenacin—Vomiting—Hydroxyurea—brain cancer	0.000749	0.00292	CcSEcCtD
Darifenacin—Rash—Hydroxyurea—brain cancer	0.000742	0.0029	CcSEcCtD
Darifenacin—Confusional state—Etoposide—brain cancer	0.000742	0.00289	CcSEcCtD
Darifenacin—Dermatitis—Hydroxyurea—brain cancer	0.000742	0.00289	CcSEcCtD
Darifenacin—Headache—Hydroxyurea—brain cancer	0.000738	0.00288	CcSEcCtD
Darifenacin—Anaphylactic shock—Etoposide—brain cancer	0.000736	0.00287	CcSEcCtD
Darifenacin—Infection—Etoposide—brain cancer	0.000731	0.00285	CcSEcCtD
Darifenacin—Abdominal pain—Temozolomide—brain cancer	0.000727	0.00284	CcSEcCtD
Darifenacin—Tachycardia—Etoposide—brain cancer	0.000718	0.0028	CcSEcCtD
Darifenacin—Skin disorder—Etoposide—brain cancer	0.000715	0.00279	CcSEcCtD
Darifenacin—Hyperhidrosis—Etoposide—brain cancer	0.000712	0.00277	CcSEcCtD
Darifenacin—Hypersensitivity—Carmustine—brain cancer	0.000701	0.00273	CcSEcCtD
Darifenacin—Nausea—Hydroxyurea—brain cancer	0.000699	0.00273	CcSEcCtD
Darifenacin—Asthenia—Carmustine—brain cancer	0.000683	0.00266	CcSEcCtD
Darifenacin—Hypersensitivity—Temozolomide—brain cancer	0.000678	0.00264	CcSEcCtD
Darifenacin—Asthenia—Temozolomide—brain cancer	0.00066	0.00257	CcSEcCtD
Darifenacin—Dyspnoea—Etoposide—brain cancer	0.000656	0.00256	CcSEcCtD
Darifenacin—Somnolence—Etoposide—brain cancer	0.000654	0.00255	CcSEcCtD
Darifenacin—Diarrhoea—Carmustine—brain cancer	0.000651	0.00254	CcSEcCtD
Darifenacin—Pruritus—Temozolomide—brain cancer	0.000651	0.00254	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Etoposide—brain cancer	0.000635	0.00248	CcSEcCtD
Darifenacin—Dizziness—Carmustine—brain cancer	0.000629	0.00245	CcSEcCtD
Darifenacin—Pain—Etoposide—brain cancer	0.000629	0.00245	CcSEcCtD
Darifenacin—Constipation—Etoposide—brain cancer	0.000629	0.00245	CcSEcCtD
Darifenacin—Diarrhoea—Temozolomide—brain cancer	0.000629	0.00245	CcSEcCtD
Darifenacin—Dizziness—Temozolomide—brain cancer	0.000608	0.00237	CcSEcCtD
Darifenacin—Feeling abnormal—Etoposide—brain cancer	0.000607	0.00237	CcSEcCtD
Darifenacin—Vomiting—Carmustine—brain cancer	0.000605	0.00236	CcSEcCtD
Darifenacin—Gastrointestinal pain—Etoposide—brain cancer	0.000602	0.00235	CcSEcCtD
Darifenacin—Rash—Carmustine—brain cancer	0.0006	0.00234	CcSEcCtD
Darifenacin—Dermatitis—Carmustine—brain cancer	0.0006	0.00234	CcSEcCtD
Darifenacin—Headache—Carmustine—brain cancer	0.000596	0.00233	CcSEcCtD
Darifenacin—Vomiting—Temozolomide—brain cancer	0.000585	0.00228	CcSEcCtD
Darifenacin—Abdominal pain—Etoposide—brain cancer	0.000582	0.00227	CcSEcCtD
Darifenacin—Rash—Temozolomide—brain cancer	0.00058	0.00226	CcSEcCtD
Darifenacin—Dermatitis—Temozolomide—brain cancer	0.000579	0.00226	CcSEcCtD
Darifenacin—Headache—Temozolomide—brain cancer	0.000576	0.00225	CcSEcCtD
Darifenacin—Nausea—Carmustine—brain cancer	0.000565	0.0022	CcSEcCtD
Darifenacin—Nausea—Temozolomide—brain cancer	0.000546	0.00213	CcSEcCtD
Darifenacin—Hypersensitivity—Etoposide—brain cancer	0.000542	0.00211	CcSEcCtD
Darifenacin—Methadone—CYP2C9—brain cancer	0.000534	0.369	CrCbGaD
Darifenacin—Asthenia—Etoposide—brain cancer	0.000528	0.00206	CcSEcCtD
Darifenacin—Pruritus—Etoposide—brain cancer	0.000521	0.00203	CcSEcCtD
Darifenacin—Diarrhoea—Etoposide—brain cancer	0.000504	0.00196	CcSEcCtD
Darifenacin—Dizziness—Etoposide—brain cancer	0.000487	0.0019	CcSEcCtD
Darifenacin—Vomiting—Etoposide—brain cancer	0.000468	0.00183	CcSEcCtD
Darifenacin—Rash—Etoposide—brain cancer	0.000464	0.00181	CcSEcCtD
Darifenacin—Dermatitis—Etoposide—brain cancer	0.000464	0.00181	CcSEcCtD
Darifenacin—Headache—Etoposide—brain cancer	0.000461	0.0018	CcSEcCtD
Darifenacin—Nausea—Etoposide—brain cancer	0.000437	0.00171	CcSEcCtD
Darifenacin—CHRM4—Signaling Pathways—HES5—brain cancer	6.23e-06	0.00223	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PTCH2—brain cancer	6.16e-06	0.0022	CbGpPWpGaD
Darifenacin—CHRM5—Regulation of Actin Cytoskeleton—EGFR—brain cancer	6.15e-06	0.0022	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—STRADA—brain cancer	6.05e-06	0.00216	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HES5—brain cancer	5.97e-06	0.00213	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—TRPC6—brain cancer	5.96e-06	0.00213	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—STRADA—brain cancer	5.8e-06	0.00207	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—ABR—brain cancer	5.77e-06	0.00206	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—ABR—brain cancer	5.75e-06	0.00205	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—DTX2—brain cancer	5.73e-06	0.00205	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—DTX2—brain cancer	5.71e-06	0.00204	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—TRPC6—brain cancer	5.71e-06	0.00204	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—ABR—brain cancer	5.69e-06	0.00203	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—DTX2—brain cancer	5.65e-06	0.00202	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—SHH—brain cancer	5.61e-06	0.002	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—TRPC6—brain cancer	5.41e-06	0.00193	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—SHH—brain cancer	5.38e-06	0.00192	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—PTCH1—brain cancer	5.32e-06	0.0019	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—SMO—brain cancer	5.32e-06	0.0019	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	5.2e-06	0.00186	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—TRPC6—brain cancer	5.18e-06	0.00185	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—PTCH1—brain cancer	5.1e-06	0.00182	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—SMO—brain cancer	5.1e-06	0.00182	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—ABR—brain cancer	5.05e-06	0.0018	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—GLI2—brain cancer	4.88e-06	0.00174	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—ABR—brain cancer	4.84e-06	0.00173	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—GLI2—brain cancer	4.67e-06	0.00167	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CYP2C9—brain cancer	4.61e-06	0.00165	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—GLI1—brain cancer	4.59e-06	0.00164	CbGpPWpGaD
Darifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	4.59e-06	0.00164	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—VEGFA—brain cancer	4.58e-06	0.00164	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—VAV1—brain cancer	4.47e-06	0.00159	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—GLI1—brain cancer	4.39e-06	0.00157	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—SUFU—brain cancer	4.35e-06	0.00155	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PTCH2—brain cancer	4.34e-06	0.00155	CbGpPWpGaD
Darifenacin—CHRM1—Regulation of Actin Cytoskeleton—EGFR—brain cancer	4.33e-06	0.00155	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PTCH2—brain cancer	4.33e-06	0.00155	CbGpPWpGaD
Darifenacin—CHRM3—Regulation of Actin Cytoskeleton—EGFR—brain cancer	4.32e-06	0.00154	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PTCH2—brain cancer	4.28e-06	0.00153	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—VAV1—brain cancer	4.28e-06	0.00153	CbGpPWpGaD
Darifenacin—CHRM2—Regulation of Actin Cytoskeleton—EGFR—brain cancer	4.27e-06	0.00153	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HES5—brain cancer	4.2e-06	0.0015	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—GFAP—brain cancer	4.2e-06	0.0015	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HES5—brain cancer	4.19e-06	0.0015	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SUFU—brain cancer	4.16e-06	0.00149	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HES5—brain cancer	4.15e-06	0.00148	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—STRADA—brain cancer	4.08e-06	0.00146	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—STRADA—brain cancer	4.07e-06	0.00145	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—VAV1—brain cancer	4.06e-06	0.00145	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—STRADA—brain cancer	4.03e-06	0.00144	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—TRPC6—brain cancer	4.02e-06	0.00144	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—GFAP—brain cancer	4.02e-06	0.00143	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—TRPC6—brain cancer	4.01e-06	0.00143	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HEY1—brain cancer	3.98e-06	0.00142	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—TRPC6—brain cancer	3.97e-06	0.00142	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—BSG—brain cancer	3.92e-06	0.0014	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—DLL1—brain cancer	3.9e-06	0.00139	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—VAV1—brain cancer	3.88e-06	0.00139	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HEY1—brain cancer	3.81e-06	0.00136	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—SHH—brain cancer	3.79e-06	0.00135	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—SHH—brain cancer	3.77e-06	0.00135	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—SHH—brain cancer	3.74e-06	0.00133	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—DLL1—brain cancer	3.73e-06	0.00133	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—TRPC6—brain cancer	3.65e-06	0.0013	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—TRPC6—brain cancer	3.64e-06	0.0013	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—TRPC6—brain cancer	3.6e-06	0.00129	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—SMO—brain cancer	3.59e-06	0.00128	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PTCH1—brain cancer	3.59e-06	0.00128	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PTCH1—brain cancer	3.58e-06	0.00128	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—SMO—brain cancer	3.58e-06	0.00128	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—SMO—brain cancer	3.54e-06	0.00126	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PTCH1—brain cancer	3.54e-06	0.00126	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ABR—brain cancer	3.41e-06	0.00122	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ABR—brain cancer	3.4e-06	0.00121	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—IDH1—brain cancer	3.37e-06	0.0012	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ABR—brain cancer	3.36e-06	0.0012	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—SHH—brain cancer	3.32e-06	0.00118	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GLI2—brain cancer	3.29e-06	0.00117	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GLI2—brain cancer	3.28e-06	0.00117	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GLI2—brain cancer	3.25e-06	0.00116	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	3.23e-06	0.00115	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	3.22e-06	0.00115	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TRPC6—brain cancer	3.2e-06	0.00114	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SHH—brain cancer	3.18e-06	0.00113	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PTCH1—brain cancer	3.14e-06	0.00112	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—SMO—brain cancer	3.14e-06	0.00112	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GLI1—brain cancer	3.09e-06	0.0011	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GLI1—brain cancer	3.08e-06	0.0011	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TRPC6—brain cancer	3.06e-06	0.00109	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GLI1—brain cancer	3.05e-06	0.00109	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—VAV1—brain cancer	3.01e-06	0.00108	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SMO—brain cancer	3.01e-06	0.00108	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PTCH1—brain cancer	3.01e-06	0.00108	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—VAV1—brain cancer	3e-06	0.00107	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—VAV1—brain cancer	2.97e-06	0.00106	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SUFU—brain cancer	2.93e-06	0.00105	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SUFU—brain cancer	2.92e-06	0.00104	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SUFU—brain cancer	2.89e-06	0.00103	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—TP53—brain cancer	2.86e-06	0.00102	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—PIK3CG—brain cancer	2.84e-06	0.00101	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—GFAP—brain cancer	2.83e-06	0.00101	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—GFAP—brain cancer	2.82e-06	0.00101	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—GFAP—brain cancer	2.79e-06	0.000997	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CYP2C9—brain cancer	2.76e-06	0.000985	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—VAV1—brain cancer	2.73e-06	0.000977	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—VAV1—brain cancer	2.73e-06	0.000973	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—PIK3CG—brain cancer	2.72e-06	0.00097	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—VAV1—brain cancer	2.7e-06	0.000964	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HEY1—brain cancer	2.68e-06	0.000958	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HEY1—brain cancer	2.67e-06	0.000955	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ENO2—brain cancer	2.67e-06	0.000952	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HEY1—brain cancer	2.65e-06	0.000945	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—DLL1—brain cancer	2.63e-06	0.000939	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—DLL1—brain cancer	2.62e-06	0.000936	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—DLL1—brain cancer	2.6e-06	0.000927	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—PIK3CG—brain cancer	2.58e-06	0.00092	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NOTCH2—brain cancer	2.51e-06	0.000897	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—PIK3CG—brain cancer	2.47e-06	0.000881	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NOTCH2—brain cancer	2.41e-06	0.000859	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—VAV1—brain cancer	2.4e-06	0.000856	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—BSG—brain cancer	2.34e-06	0.000837	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—VAV1—brain cancer	2.29e-06	0.000819	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SHH—brain cancer	2.24e-06	0.000798	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SHH—brain cancer	2.23e-06	0.000796	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SHH—brain cancer	2.21e-06	0.000788	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TRPC6—brain cancer	2.16e-06	0.00077	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TRPC6—brain cancer	2.15e-06	0.000767	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TRPC6—brain cancer	2.13e-06	0.00076	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PTCH1—brain cancer	2.12e-06	0.000757	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SMO—brain cancer	2.12e-06	0.000757	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PTCH1—brain cancer	2.11e-06	0.000755	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SMO—brain cancer	2.11e-06	0.000755	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SMO—brain cancer	2.09e-06	0.000747	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PTCH1—brain cancer	2.09e-06	0.000747	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—HES1—brain cancer	2.06e-06	0.000736	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—IDH1—brain cancer	2.02e-06	0.00072	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—IL2—brain cancer	2e-06	0.000713	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—HES1—brain cancer	1.97e-06	0.000705	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PDGFRA—brain cancer	1.96e-06	0.000701	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—PIK3CG—brain cancer	1.91e-06	0.000683	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—IL2—brain cancer	1.91e-06	0.000682	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—PIK3CG—brain cancer	1.91e-06	0.000681	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—SPP1—brain cancer	1.9e-06	0.00068	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—PIK3CG—brain cancer	1.89e-06	0.000674	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PDGFRA—brain cancer	1.88e-06	0.000671	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SPP1—brain cancer	1.82e-06	0.000651	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL2—brain cancer	1.81e-06	0.000647	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP2C9—brain cancer	1.8e-06	0.000644	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PIK3CG—brain cancer	1.74e-06	0.00062	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL2—brain cancer	1.74e-06	0.00062	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PIK3CG—brain cancer	1.73e-06	0.000618	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IRS2—brain cancer	1.72e-06	0.000615	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	1.71e-06	0.000612	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NOTCH2—brain cancer	1.69e-06	0.000605	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NOTCH2—brain cancer	1.69e-06	0.000603	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NOTCH2—brain cancer	1.67e-06	0.000597	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IRS2—brain cancer	1.65e-06	0.000589	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—VAV1—brain cancer	1.62e-06	0.000577	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—VAV1—brain cancer	1.61e-06	0.000575	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—VAV1—brain cancer	1.59e-06	0.000569	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ENO2—brain cancer	1.59e-06	0.000569	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—BSG—brain cancer	1.53e-06	0.000547	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PIK3CG—brain cancer	1.52e-06	0.000543	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—APC—brain cancer	1.52e-06	0.000543	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PIK3CG—brain cancer	1.46e-06	0.00052	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—APC—brain cancer	1.46e-06	0.00052	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—HES1—brain cancer	1.39e-06	0.000496	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—EGFR—brain cancer	1.39e-06	0.000495	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—HES1—brain cancer	1.38e-06	0.000495	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—HES1—brain cancer	1.37e-06	0.00049	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—IL2—brain cancer	1.35e-06	0.00048	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—IL2—brain cancer	1.34e-06	0.000479	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—IL2—brain cancer	1.33e-06	0.000474	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—EGFR—brain cancer	1.33e-06	0.000474	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PDGFRA—brain cancer	1.32e-06	0.000472	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PDGFRA—brain cancer	1.32e-06	0.000471	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—IDH1—brain cancer	1.32e-06	0.000471	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PDGFRA—brain cancer	1.31e-06	0.000466	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SPP1—brain cancer	1.28e-06	0.000459	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SPP1—brain cancer	1.28e-06	0.000457	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SPP1—brain cancer	1.27e-06	0.000453	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PIK3CG—brain cancer	1.22e-06	0.000437	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL2—brain cancer	1.22e-06	0.000436	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL2—brain cancer	1.22e-06	0.000435	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL2—brain cancer	1.21e-06	0.000431	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—RELA—brain cancer	1.19e-06	0.000424	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—ERBB2—brain cancer	1.18e-06	0.000422	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IRS2—brain cancer	1.16e-06	0.000415	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IRS2—brain cancer	1.16e-06	0.000413	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IRS2—brain cancer	1.15e-06	0.000409	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—RELA—brain cancer	1.14e-06	0.000406	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—ERBB2—brain cancer	1.13e-06	0.000404	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL2—brain cancer	1.07e-06	0.000382	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CCND1—brain cancer	1.04e-06	0.000373	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ENO2—brain cancer	1.04e-06	0.000372	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CTNNB1—brain cancer	1.03e-06	0.000369	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—APC—brain cancer	1.03e-06	0.000366	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PIK3CG—brain cancer	1.03e-06	0.000366	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL2—brain cancer	1.03e-06	0.000366	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PIK3CG—brain cancer	1.02e-06	0.000365	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—APC—brain cancer	1.02e-06	0.000365	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PIK3CG—brain cancer	1.01e-06	0.000362	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—APC—brain cancer	1.01e-06	0.000362	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CCND1—brain cancer	9.99e-07	0.000357	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CTNNB1—brain cancer	9.9e-07	0.000353	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—EGFR—brain cancer	9.35e-07	0.000334	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—EGFR—brain cancer	9.32e-07	0.000333	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—EGFR—brain cancer	9.23e-07	0.000329	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—VEGFA—brain cancer	9.1e-07	0.000325	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—STAT3—brain cancer	9.01e-07	0.000322	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—VEGFA—brain cancer	8.71e-07	0.000311	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—STAT3—brain cancer	8.63e-07	0.000308	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MYC—brain cancer	8.37e-07	0.000299	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—EGFR—brain cancer	8.19e-07	0.000292	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MYC—brain cancer	8.02e-07	0.000286	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RELA—brain cancer	8.01e-07	0.000286	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RELA—brain cancer	7.99e-07	0.000285	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ERBB2—brain cancer	7.96e-07	0.000284	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ERBB2—brain cancer	7.94e-07	0.000284	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RELA—brain cancer	7.91e-07	0.000283	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ERBB2—brain cancer	7.86e-07	0.000281	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—EGFR—brain cancer	7.84e-07	0.00028	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PIK3CG—brain cancer	7.31e-07	0.000261	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL2—brain cancer	7.22e-07	0.000258	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL2—brain cancer	7.2e-07	0.000257	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL2—brain cancer	7.13e-07	0.000254	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CCND1—brain cancer	7.04e-07	0.000251	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CCND1—brain cancer	7.01e-07	0.00025	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CTNNB1—brain cancer	6.97e-07	0.000249	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CTNNB1—brain cancer	6.95e-07	0.000248	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CCND1—brain cancer	6.95e-07	0.000248	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CTNNB1—brain cancer	6.88e-07	0.000246	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TP53—brain cancer	6.87e-07	0.000245	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TP53—brain cancer	6.58e-07	0.000235	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—VEGFA—brain cancer	6.13e-07	0.000219	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—VEGFA—brain cancer	6.11e-07	0.000218	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—STAT3—brain cancer	6.07e-07	0.000217	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—VEGFA—brain cancer	6.06e-07	0.000216	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—STAT3—brain cancer	6.05e-07	0.000216	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—STAT3—brain cancer	6e-07	0.000214	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MYC—brain cancer	5.64e-07	0.000202	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MYC—brain cancer	5.63e-07	0.000201	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MYC—brain cancer	5.57e-07	0.000199	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—EGFR—brain cancer	5.52e-07	0.000197	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—EGFR—brain cancer	5.5e-07	0.000197	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—EGFR—brain cancer	5.45e-07	0.000195	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PIK3CG—brain cancer	4.78e-07	0.000171	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TP53—brain cancer	4.64e-07	0.000166	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TP53—brain cancer	4.62e-07	0.000165	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TP53—brain cancer	4.58e-07	0.000163	CbGpPWpGaD
